Clinical Trials in Tennessee

Showing 13741-13760 of 17,345 trials

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

NCT00802867

Objectives: * To present the rates of adverse reactions after a dose of DAPTACEL® vaccine administered to children 4 to 6 years of age who have previously received four doses of PENTACEL™ vaccine. * To present immunogenicity before and after a single dose of DAPTACEL® vaccine administered to children 4 to 6 years of age who have previously received four doses of PENTACEL™ vaccine.

DiphtheriaTetanusPertussis+2 more

Sanofi Pasteur, a Sanofi Company989 participantsStarted Feb 2004

Jonesboro, Arkansas, United States • Little Rock, Arkansas, United States • Oakland, California, United States +16 more locations

UNKNOWNNA29 miles

Fat Reduction in the Flanks Area vs. Control

NCT02465775

Prospective, blinded, one arm, baseline-controlled clinical study for the evaluation the performance of the UltraShape treatment for non-invasive fat reduction by compare control and treated flanks. Study subjects will undergo UltraShape treatments on one randomized flank using the U-Sculpt/VDF Transducer. The second flank will not be treated (control). Both flanks (treated and control) will be compared to baseline, as well as, one to each other

Flanks Fat Reduction vs. Control

Syneron Medical60 participantsStarted Jul 2015

Metairie, Louisiana, United States • Hunt Valley, Maryland, United States • Nashville, Tennessee, United States

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

Fat Reduction in the Flanks Area vs. Control

Find Trials by Condition in Tennessee

Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM

Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)

VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis

Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF

ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects

Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia

Dose Comparison Study of Menactra® in US Children

The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries

Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

Health-related Quality of Life Measure in Pediatric Lupus

Diffusion Weighted Imaging Evaluation for Understanding Stroke Evolution Study-2 (DEFUSE-2)

Brief Cognitive Behavioral Therapy (CBT) for Pediatric Anxiety and Depression in Primary Care

G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator